ALK and cancer: PI3Kβ inhibition blocks ALK‐inhibition‐induced cytoprotective reactivation of EGFR signaling, enhancing the cytotoxic effect on both epithelial‐ and mesenchymal‐phenotype cancer cells without affecting normal lung epithelial cells.